There's plenty of buzz around how AI can make self-healing networks a reality -- but how close are we to that, really?

EPS growth, with buybacks, dividends and deleveraging driving 10%+ yield. Read the latest analysis on the stock here.

Utah has quietly become the test bed for one of the most radical uses of artificial intelligence in American medicine, ...